Afon Technology is pioneering advancements in diabetes care with its innovative device, Glucowear™, which is being developed as the world’s first non-invasive, real-time, continuous blood glucose monitor.
A Harvard study finds that following a Mediterranean diet can lower dementia risk for those with high genetic susceptibility, including APOE4 carriers.
Professor Susanna Price, Chair of the European Society of Cardiology’s Advocacy Committee, advocates for improved early detection and addressing inequalities in cardiovascular disease prevention, the leading cause of death worldwide.
A state-of-the-art facility in Darlington is set to fast-track the development of next-generation RNA therapies thanks to nearly £30 million in government funding.
Harvard engineers have pioneered a unique wearable robot that adapts to user movements, providing personalised assistance to enhance daily activities for stroke and ALS patients.
Scientists have developed new tests that can detect avian influenza, which is also commonly known as bird flu. These tests can detect influenza quickly and more accurately than ever before.
NIH researchers found that the brain's control centre for a lost limb persists long after amputation, challenging theories of cortical remapping. This insight into phantom limb syndrome could inform future neuroprosthetic and pain treatments.
Drs Francesc Xavier Cos Claramunt and Carmen Hurtado, representatives of the European Diabetes Forum (EUDF), discuss the prevalence and challenges associated with diabetes management and the health-related policies needed to support prevention and early diagnosis.
As more older adults live with dementia, frailty, and multiple long-term conditions, health and social care systems must adapt to deliver truly coordinated, person-centred support.
Stanford researchers have created a brain-computer interface that translates imagined speech into text, enabling communication for individuals with severe paralysis.
